Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1271-1281

  Stoll, Stefan ^a   Garner, Warren ^b   Elder, James ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Epidermal growth factor urogastrone receptor; Receptor protein tyrosine kinase; Skin; Transforming growth factor alpha; Wound healing

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; AMPHIREGULIN; CALCEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN; IMMUNOGLOBULIN G; KERATIN; LIGAND; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; PRIORITY JOURNAL; SKIN CULTURE; SPLIT THICKNESS SKIN GRAFT; WOUND HEALING;

EID: 0030884044     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119641     Document Type: Article

References (60)

1. Clark, R.A.F. 1996. The Molecular and Cellular Biology of Wound Repair. Plenum Publishing Corporation, New York. 611 pgs.
2. Mansbridge, J.N., and A.M. Knapp. 1987. Changes in keratinocyte maturation during wound healing. J. Investig. Dermatol. 89 (3):253-263.
3. Werner, S., H. Smola, X. Liao, M.T. Longaker, T. Krieg, P.H. Hofschneider, and L.T. Williams. 1994. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (Wash. DC). 266 (5186): 819-822.
4. Elder, J. 1994. Transforming growth factor-alpha and related growth factors. In Epidermal Growth Factors and Cytokines. T. Luger and T. Schwarz, editors. Marcel Dekker, Inc., New York. 205-240.
5. Nanney, L.B., and L.E. King. 1996. Epidermal growth factor and transforming growth factor-alpha. In The Molecular and Cellular Biology of Wound Repair. R.A.F. Clark, editor. Plenum Publishing Corporation, New York.
6. Barnard, J.A., R. Graves Deal, M.R. Pittelkow, R. DuBois, P. Cook, G.W. Ramsey, P.R. Bishop, L. Damstrup, and R.J. Coffey. 1994. Auto-and cross-induction within the mammalian epidermal growth factor-related peptide family. J Biol. Chem. 269 (36):22817-22822.
7. Coffey, R.J., Jr., R. Derynck, J.N. Wilcox, T.S. Bringman, A.S. Goustin, H.L. Moses, and M.R. Pittelkow. 1987. Production and auto-induction of transforming growth factor-alpha in human keratinocytes. Nature (Lond.). 328 (6133):817-820.
8. Cook, P.W., P.A. Mattox, W.W. Keeble, M.R. Pittelkow, G.D. Plowman, M. Shoyab, J.P. Adelman, and G.D. Shipley. 1991. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin Mol. Cell Biol. 11 (5):2547-2557.
9. Hashimoto, K., S. Higashiyama, H. Asada, E. Hashimura, T. Kobayashi, K. Sudo, T. Nakagawa, D. Damm, K. Yoshikawa, and N. Taniguchi. 1994. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J. Biol. Chem. 269 (31):20060-20066.
10. Coffey, R., Jr., R. Graves-Deal, P.J. Dempsey, R.H. Whitehead, and M.R. Pittelkow. 1992. Differential regulation of transforming growth factor alpha autoinduction in nontransformed and transformed epithelial cell. Cell Growth Differ. 3 (6):347-354.
11. Stoll, S.W., and J.T. Elder. 1995. EGF receptor activation regulates expression of multiple keratinocyte-derived growth factor rnRNAs by increasing transcript stability. J. Investig. Dermatol. 104 (4):675a (Abstr.).
12. Beerli, R.R., D. Graus Porta, K. Woods Cook, X. Chen, Y. Yarden, and N.E. Hynes. 1995. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell-specific and displays a differential requirement for ErbB-2. Mol. Cell Biol. 15 (12):6496-6505.
13. Poumay, Y., and M.R. Pittelkow. 1995. NDF/heregulins are expressed by proliferating cultured keratinocytes, but activate HER2 only in growth-arrested cultures and suppress expression of differentiation markers. J. Investig. Dermatol. 104:574a (Abstr.).
14. Danilenko, D.M., B.D. Ring, J.Z. Lu, J.E. Tarpley, D. Chang, N. Liu, D. Wen, and G.F. Pierce. 1995. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J. Clin. Invest. 95 (2): 842-851.
15. Klein, S.B., G.J. Fisher, T.C. Jensen, J. Mendelsohn, J.J. Voorhees, and J.T. Elder. 1992. Regulation of TGF-alpha expression in human keratinocytes: PKCdependent and independent pathways. J. Cell Physiol. 151 (2):326-336.
16. Elder, J.T., C.I. Sartor, D.K. Boman, S. Benrazavi, G.J. Fisher, and M.R. Pittelkow. 1992. Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch. Dermatol. Res. 284 (6):324-332.
17. Carpenter, G., and S. Cohen. 1990. Epidermal growth factor. J. Biol. Chem. 265 (14):7709-7712.
18. Stoscheck, C.M., L.B. Nanney, and L.E. King, Jr. 1992. Quantitative determination of EGF-R during epidermal wound healing. J. Investig. Dermatol. 99 (5):645-649.
19. Detmar, M., K.-T. Yeo, J. Nagy, L. Van De Water, L. Brown, B.R. Berse, S. Ledbetter, and H. Dvorak. 1995. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Investig. Dermatol. 105:44-50.
20. Paladini, R.D., K. Takahashi, N.S. Bravo, and P.A. Coulombe. 1996. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J. Cell Biol. 132 (3):381-397.
21. Jiang, C.K., T. Magnaldo, M. Ohtsuki, I.M. Freedberg, F. Bernerd, and M. Blumenberg. 1993. Epidermal growth factor and transforming growth factor alpha specifically induce the activation-and hyperproliferation-associated keratins 6 and 16. Proc. Natl. Acad. Sci. USA. 90 (14):6786-6790.
22. Taipale, J., K. Koli, and J. Keski-Oja. 1992. Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J. Biol. Chem. 267 (35):25378-25384.
23. Grant, G.A., G.I. Goldberg, S.M. Wilhelm, C. He, and A.Z. Eisen. 1992. Activation of extracellular matrix metalloproteases by proteases and organomercurials. Matrix Suppl. 1:217-223.
24. Bugge, T.H., K.W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.L. Degen. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell. 87 (4):709-719.
25. Jensen, P.J., and U. Rodeck. 1993. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-alpha/EGF receptor. J. Cell. Physiol. 155 (2):333-339.
26. Brown, G.L., L.B. Nanney, J. Griffen, A.B. Cramer, J.M. Yancey, L.D. Curtsinger, L. Holtzin, G.S. Schultz, M.J. Jurkiewicz, and J.B. Lynch. 1989. Enhancement of wound healing by topical treatment with epidermal growth factor [see comments]. N. Engl. J. Med. 321(2):76-79.
27. Nanney, L.B. 1990. Epidermal and dermal effects of epidermal growth factor during wound repair. J. Investig. Dermatol. 94 (5):624-629.
28. Rheinwald, J., and H. Green. 1977. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature (Lond.). 265 (5593):421-424.
29. Elder, J.T., A. Tavakkol, S.B. Klein, M.E. Zeigler, M. Wicha, and J.J. Voorhees. 1990. Protooncogene expression in normal and psoriatic skin. J. Investig. Dermatol. 94 (1):19-25.
30. Hebda, P.A. 1988. Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J. Investig. Dermatol. 91 (5):440-445.
31. Garner, W.L., J.L. Rodriguez, C.G. Miller, G.O. Till, R.S. Rees, D.J. Smith and D.G. Remick. 1994. Acute skin injury releases neutrophil chemoattractants. Surgery (St. Louis). 116 (1):42-48.
32. Fry, D.W., A.J. Kraker, A. McMichael, L.A. Ambroso, J.M. Nelson, W.R. Leopold, R.W. Connors, and A.J. Bridges. 1994. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Wash. DC). 265: 1093-1095.
33. Sunada, H., B.E. Magun, J. Mendelsohn, and C.L. MacLeod. 1986. Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc. Natl. Acad. Sci. USA. 83 (11):3825-3829.
34. Voorhees, J.J., E.A. Duell, L.J. Bass, J.A. Powell, and E.R. Harrell. 1972. Decreased cyclic AMP in the epidermis of lesions of psoriasis. Arch. Dermatol. 105 (5):695-701.
35. Elder, J.T., G.J. Fisher, Q.Y. Zhang, D. Eisen, A. Krust, P. Kastner, P. Chambon, and J.J. Voorhees. 1991. Retinoic acid receptor gene expression in human skin. J. Investig. Dermatol. 96 (4):425-433.
36. Pittelkow, M.R., J. Wille, Jr., and R.E. Scott. 1986. Two functionally distinct classes of growth arrest states in human prokeratinocytes that regulate clonogenic potential. J. Investig. Dermatol. 86 (4):410-417.
37. Elder, J.T., G.J. Fisher, P.B. Lindquist, G.L. Bennett, M.R. Pittelkow, R. Coffey, Jr., L. Ellingsworth, R. Derynck, and J.J. Voorhees. 1989. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (Wash. DC). 243 (4892):811-814.
38. Elder, J., A. Kaplan, M. Cromie, S. Kang, and J. Voorhees. 1996. Retinoid induction of CRABP II rnRNA in human fibroblasts: use as a retinoid bioassay. J. Investig. Dermatol. 106 (3):517-521.
39. Plowman, G.D., J.M. Green, V.L. McDonald, M.G. Neubauer, C.M. Disteche, G.J. Todaro, and M. Shoyab. 1990. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. Cell Biol. 10 (5):1969-1981.
40. Leung, D.W., G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrar. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Wash. DC). 246 (4935):1306-1309.
41. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl, L.M. Albright, D.M. Coen, and A. Varki. 1988. Current protocols in molecular biology. Vol. 1. K. Janssen, editor. Wiley and Sons, New York.
42. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227 (259):680-685.
43. Papadopoulos, N.G., G.V. Dedoussis, G. Spanakos, A.D. Gritzapis, C.N. Baxevanis, and M. Papamichail. 1994. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J. Immunol. Methods. 177 (1-2):101-111.
44. Reaven, E.P., and A.J. Cox. 1968. Behavior of adult human skin in organ culture. II. Effects of cellophane tape stripping, temperature, oxygen tension, pH and serum. J. Investig. Dermatol. 50 (2):118-128.
45. Sarkany, I., K. Grice, and G.A. Caron. 1965. Organ culture of adult human skin. Br. J. Dermatol. 77:65-76.
46. Bhora, F.Y., B.J. Dunkin, S. Batzri, H.M. Aly, B.L. Bass, A.N. Sidawy, and J.W. Harmon. 1995. Effect of growth factors on cell proliferation and epithelialization in human skin. J. Surg. Res. 59 (2):236-244.
47. Eisen, A.Z. 1969. Human skin collagenase: localization and distribution in normal human skin. J. Investig. Dermatol. 52 (5):442-448.
48. Morioka, S., G.S. Lazarus, and P.J. Jensen. 1987. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J. Investig. Dermatol. 89 (5):474-478.
49. Marks, R., B. Bhogal, and R.P. Dawber. 1972. The migratory property of epidermis in vitro. Arch. Dermatol. Forsch. 243 (3):209-220.
50. Mackie, E.J., W. Halfter, and D. Liverani. 1988. Induction of tenascin in healing wounds. J. Cell Biol. 107 (6 Pt 2):2757-2767.
51. Dvorak, H.F., L.F. Brown, M. Detmar, and A.M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am. J. Pathol. 146 (5):1029-1039.
52. Rheinwald, J.G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6 (3):331-343.
53. Wille, J., Jr., M.R. Pittelkow, G.D. Shipley, and R.E. Scott. 1984. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J. Cell. Physiol. 121 (1):31-44.
54. Thomas, G., J. Martin-Perez, M. Siegmann, and A.M. Otto. 1982. The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell. 30 (1):235-242.
55. Marikovsky, M., P. Vogt, E. Eriksson, J.S. Rubin, W.G. Taylor, J. Sasse, and M. Klagsbrun. 1996. Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J. Investig. Dermatol. 106 (4):616-621.
56. Meunier, L., Z. Bata-Csorgo, and K.D. Cooper. 1945. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1-macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J. Investig. Dermatol. 105 (6):782-788.
57. McCarthy, D.W., M.T. Downing, D.R. Brigstock, M.H. Luquette, K.D. Brown, M.S. Abad, and G.E. Besner. 1996. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients. J. Investig. Dermatol. 106 (1):49-56.
58. Flaumenhaft, R., and D.B. Rifkin. 1992. The extracellular regulation of growth factor action. Mol. Biol. Cell. 3 (10):1057-1065.
59. Cook, P.W., N.M. Ashton, C.E. Karkaria, D.C. Siess, and G.D. Shipley. 1995. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity. J. Cell. Physiol. 163 (2):418-429.
60. Schalkwijk, J., P.M. Steijlen, I.M. van Vlijmen-Willems, B. Oosterling, E.J. Mackie, and A.A. Verstraeten. 1991. Tenascin expression in human dermis is related to epidermal proliferation. Am. J. Pathol. 139 (5):1143-1150.